Multiple cutaneous telangiectasias after the use of trastuzumab: a case report

Abstract

We aim to report a particular case of cutaneous telangiectasias on the arms after immunotherapy with trastuzumab plus paclitaxel to treat breast cancer. New oncology therapies reflect a major advance in cancer treatment. They greatly increase survival; however, they still cause certain adverse cutaneous events that should be taken into account for their proper management.

Keywords

• Antineoplastic Agents
• Side Effect
• Vascular Skin Disease
• Dermatology
• Medical Oncology
• Breast Cancer